CLINICAL CHEMISTRY ALBUMIN BCP 7D54-20

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01,05 report with the FDA on 2009-11-17 for CLINICAL CHEMISTRY ALBUMIN BCP 7D54-20 manufactured by Abbott Manufacturing, Inc..

Event Text Entries

[1305973] The account stated that after calibrating the architect albumin bcp reagent with the new mcc calibrator lot 73223m200, there was a downward shift in the control values. This also occurred on the second architect analyzer. The account resolved the issue by increasing the calibration factors. There was no adverse impact to patient management reported. This is a user report.
Patient Sequence No: 1, Text Type: D, B5


[8364698] (b)(4). Concomitant medical products: mcc calibrators list 1e65-04 lot 73223m200. This is an initial report. An investigation is in process. A final report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


[8508868] (b)(4). Clinical chemistry multiconstituent calibrator lot 73223m200 expiration date 6/30/2010. Albumin p reagent list 7d54-20, lot 78021hw00 manufactured date 6/30/2009. Expiration date 6/10/2010. Results of the supplemental investigation are as follows: the customers quality control (qc) values for albumin shifted low with first use of cc mcc, ln 1e65-04, lot 73223m200 while using clinical chemistry (cc) albumin bcp (albp) reagent lot 74003hw00 on two architect ci8200 systems. The customer was previously using cc mcc lot 63421m100 without any issue. For this investigation, cc albp reagent lots 74003hw00 and 76015hw00 were calibrated with cc mcc lots 63421m100, 73223m200, and 77118m200. Bio-rad unassayed lyphochek and assayed multiqual control mean values were compared to evaluate lot to lot variability between the calibrator and reagent lot combinations. Testing was performed on 3 architect systems. All control values were within the established ranges. In-house testing demonstrated the control values from cc albp obtained using cc mcc lot 73223m200 are lower than those generated with cc mcc lot 63421m100, however they are within established ranges. Since the controls are within the acceptable ranges, cc mcc (ln 1e65-04) lots 63421m100, 73223m200, and 77118m200 and cc albp reagent lots 74003hw00 and 76015hw00 are performing within specifications. No product deficiency could be determined.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2018433-2009-00047
MDR Report Key1530891
Report Source01,05
Date Received2009-11-17
Date of Report2009-10-28
Date Mfgr Received2009-12-29
Device Manufacturer Date2008-10-06
Date Added to Maude2010-03-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street200 ABBOTT PARK ROAD DEPT. 09B9, AP50
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT MANUFACTURING, INC.
Manufacturer Street820 MISSION ST.
Manufacturer CitySOUTH PASADENA CA 91030
Manufacturer CountryUS
Manufacturer Postal Code91030
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCLINICAL CHEMISTRY ALBUMIN BCP
Generic NameFOR THE QUANTITATION OF ALBUMIN IN HUMAN SERUM OR PLASMA
Product CodeCJW
Date Received2009-11-17
Catalog Number7D54-20
Lot Number69053HW00
Device Expiration Date2009-10-02
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING, INC.
Manufacturer Address820 MISSION ST. SOUTH PASADENA CA 91030 US 91030


Patients

Patient NumberTreatmentOutcomeDate
10 2009-11-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.